TIGIT and neoplasm: Another immune-checkpoint molecule, the T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain (TIGIT), was shown to mediate NK cell exhaustion in cancer, with the blockade of TIGIT restoring the anti-tumour activity of NK cells16.